The US Supreme Court unanimously upheld access to the abortion pill Mifepristone, marking a significant victory for reproductive health rights.

Anti-abortion activists had challenged the FDA's approval of Mifepristone, highlighting ongoing threats to abortion rights.

The ruling maintains access to medication abortion but does not guarantee the future of reproductive rights in the US.

States and advocates may continue to push for restrictions despite the court's decision.

The decision was based on the lack of legal standing for anti-abortion doctors to sue, leaving room for further challenges.

This underscores the importance of supporting candidates who will safeguard reproductive rights through legislative solutions at both the state and federal levels.